Bio News
The Ministry of Health and Welfare issued a legislative notice on an amendment that would divide innovative pharmaceutical companies into “leading” and “leaping” categories.
Companies scoring 65 points or higher in the evaluation will be certified as leading, while those scoring below 65 points will be certified as leaping.
The Ministry of Health and Welfare plans to begin soliciting applications for new certification of leaping companies after gathering public comments.
Biobook Team
biobookmedia@biobook.co.krRoche’s New Drug for Uveitic Macular Edema Faces FDA Decision in July 2027
BMS Reports Concurrent Phase 3 Success in Idiopathic Pulmonary Fibrosis and Solid Tumors
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
